EichorEICHOR
Condition: Advanced Adult Hepatocellular Carcinoma Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Advanced Adult Hepatocellular Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Phase N/A · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT03894917IDOV-Immune for Advanced Solid Tumors
Phase 1 · 5 location(s) · ViroMissile, Inc. · NCT06910657A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · 11 location(s) · AbbVie · NCT06487559PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
Phase 1 · 1 location(s) · Chinese PLA General Hospital · NCT07018518A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Phase 1 · 2 location(s) · LaunXP Biomedical Co., Ltd. · NCT06883539Radioembolization With Intra-arterial Angiotensin II to Improve Tumor-absorbed Dose (RADIANT)
Phase 2 · 1 location(s) · Niek Wijnen · NCT07312292Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07500220Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07523529First in Human Study of SIM0610 in Solid Tumors
Phase 1 · 7 location(s) · Jiangsu Simcere Pharmaceutical Co., Ltd. · NCT07348211Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatmen
Phase 1/Phase 2 · 49 location(s) · Pfizer · NCT07227012Study of GV20-0251 in Participants With Solid Tumor Malignancies
Phase 1/Phase 2 · 3 location(s) · GV20 Therapeutics · NCT07070518Mts105 for Advanced Hepatocellular Carcinoma
Phase 1 · 1 location(s) · Shen Lin · NCT06689540Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT04803318A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solut
Phase 2/Phase 3 · 37 location(s) · AbbVie · NCT06109272A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Phase 1 · 9 location(s) · Myeloid Therapeutics · NCT06478693First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Phase 1/Phase 2 · 20 location(s) · AstraZeneca · NCT06795022Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Phase 1 · 3 location(s) · BioEclipse Therapeutics · NCT04282044Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With
Phase 1 · 16 location(s) · Tyra Biosciences, Inc · NCT06915753GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
Phase 1/Phase 2 · 8 location(s) · Eureka Therapeutics Inc. · NCT04864054Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT04770207
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.